Finance

Lists
ORYZF:OTCMKTS
Oryzon Genomics SA
$3.10
0.00%
(0.00) 1D
Sep 30, 2:30:04 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ORYZF...
Mkt. cap
217.42M
Avg. vol.
113.00
Volume
0.00
52-wk high
$3.70
52-wk low
$3.10
Beta
-605.79
Shares outstanding
84.33M
No. of employees
46
Mkt. cap
217.42M
Avg. vol.
113.00
Volume
0.00
52-wk high
$3.70
52-wk low
$3.10
Beta
-605.79
Shares outstanding
84.33M
No. of employees
46
News stories
From web sources and news partners
About Oryzon Genomics SA
CEOCarlos Buesa
Employees46
Founded2000
Headquarters-
SectorBiotechnology
Websiteoryzon.com
Previous reportsAll values in EUR
Loading Previous Earnings...
Revenue
Net income
All values in EUR
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
10.93M
-
8.69M
Cost of goods sold
-
282.49K
-
210.97K
Cost of revenue
-
282.49K
-
210.97K
Research and development expenses
-
-8.20M
-
-4.53M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
-
480.49K
-
793.29K
Operating expense
-
4.85M
-
5.81M
Total operating expenses
-
5.14M
-
6.02M
Operating income
-
5.80M
-
2.67M
Other non operating income
-
-8.22M
-
-4.09M
EBT including unusual items
-
-4.34M
-
-1.97M
EBT excluding unusual items
-
-4.34M
-
-2.00M
Income tax expense
-
-2.99M
-
-1.83M
Effective tax rate
-
68.94%
-
93.12%
Other operating expenses
-
12.44M
-
9.48M
Net income
-
-1.35M
-
-135.49K
Net profit margin
-
-12.33%
-
-1.56%
Earnings per share
0.01
-0.02
-0.02
-
Interest and investment income
-
-
-
-
Interest expense
-
-1.98M
-
-619.42K
Net interest expenses
-
-1.98M
-
-619.42K
Depreciation and amortization charges
-
133.91K
-
62.62K
EBITDA
-
5.83M
-
2.70M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps